サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1401002

PEG化タンパク質市場：タンパク質タイプ別、用途別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年

PEGylated Proteins Market, By Protein Type, By Application, By End-Use, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 282 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
PEG化タンパク質市場：タンパク質タイプ別、用途別、最終用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2023-2030年
出版日: 2023年12月17日
発行: AnalystView Market Insights
ページ情報: 英文 282 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートのハイライト

PEG化タンパク質の市場規模は2022年に144億2,430万米ドルと評価され、2023年から2030年にかけてCAGR 4.7%で拡大すると予想されます。

PEG化タンパク質市場- 市場力学

生物学的製剤治療における治療効果と患者体験を向上させる必要性が市場需要を促進

PEG化には、薬剤の体内循環の増加、免疫原性の低下、安定性の向上など、さまざまな利点があります。これにより、投与回数を減らすことができ、患者のコンプライアンスを向上させ、慢性疾患治療の負担を軽減することができます。さらに、PEG化は副作用や有害反応を減少させ、生物製剤を患者にとってより耐えやすく安全なものにする可能性があります。その結果、製薬会社や研究者は、現在の生物製剤を最適化し、革新的な治療法を開発するための技術としてPEG化の研究を続けており、最終的には医療の転帰を改善することを目標としています。

PEG化タンパク質市場-主な洞察

弊社のリサーチアナリストの分析によると、世界のPEG化タンパク質市場は、予測期間（2023-2030年）に約4.7%のCAGRで毎年成長すると予測されています。

PEG化タンパク質産業は、生物学的製剤治療における治療効果と患者体験を向上させる必要性から、著しい速度で成長すると予測されています。

タンパク質タイプ別セグメンテーションでは、コロニー刺激因子が2022年に最大の市場シェアを示すとなっています。

用途別では、自己免疫疾患が2022年の主要なタンパク質タイプでした。

地域別では、北米が2022年の収益でリードしています。

PEG化タンパク質市場-セグメンテーション分析：

PEG化タンパク質の世界市場は、タンパク質タイプ、用途、最終用途、地域に基づいてセグメント化されます。

市場はタンパク質タイプに基づいて4つのカテゴリーに分けられる：コロニー刺激因子、インターフェロン、エリスロポエチン、その他。コロニー刺激因子は市場を独占しています。PEG化タンパク質、特にPEG化コロニー刺激因子は、様々な医薬用途での使用により高い需要があります。血液細胞の生成を増加させるコロニー刺激因子は、がん、貧血、免疫不全症などの病気における治療効果を向上させるためにPEG化されることが多いです。

市場は用途によって3つのカテゴリーに分けられる：がん、自己免疫疾患、肝炎、多発性硬化症、血友病、消化器系疾患、その他です。自己免疫疾患分野が市場を独占しており、予測期間中もその優位性は維持されるとみられます。PEG化タンパク質は自己免疫疾患に使用する需要が高いです。これらの生物製剤は、ポリエチレングリコール（PEG）を用いて自己免疫関連タンパク質を変化させることで免疫反応を調節し、炎症を低下させることにより、関節リウマチ、多発性硬化症、ループスなどの疾患の治療において、半減期の延長と有効性の向上をもたらす可能性があります。

PEG化タンパク質市場-地理的洞察

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスをもたらす国によってさらに分けられます。北米のPEG化タンパク質市場にはいくつかの変数が影響しています。この地域は、革新的な生物学的医薬品の開発と商業化に専念する、確立された製薬とバイオテクノロジー部門を誇っています。また、がん、自己免疫疾患、血液疾患などの慢性疾患の頻度が増加していることから、オーダーメイドの生物学的治療に対するニーズが高まっています。さらに、北米の規制枠組みは技術革新を促進し、PEG化タンパク質のような革新的な医薬製剤の開発を促進し、治療効果と患者のコンプライアンスを向上させています。最後に、この地域の強力な医療・インフラと最先端の治療法の利用可能性は、PEG化タンパク質治療薬にとって良好な市場であり、この分野への継続的な研究と投資に拍車をかけています。

目次

第1章 PEG化タンパク質市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 PEG化タンパク質の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 PEG化タンパク質産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 PEG化タンパク質市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 PEG化タンパク質市場情勢

  • PEG化タンパク質市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 PEG化タンパク質市場：タンパク質タイプ別

  • 概要
    • タンパク質タイプ別のセグメントシェア分析
    • コロニー刺激因子
    • インターフェロン
    • エリスロポエチン
    • その他

第8章 PEG化タンパク質市場：用途別

  • 概要
    • 用途別のセグメントシェア分析
    • がん
    • 自己免疫疾患
    • 肝炎
    • 多発性硬化症
    • 血友病
    • 消化器系疾患
    • その他

第9章 PEG化タンパク質市場：最終用途別

  • 概要
    • 最終用途別のセグメントシェア分析
    • 製薬・バイオテクノロジー企業
    • CRO
    • 学術・研究機関

第10章 PEG化タンパク質市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東およびアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：PEG化タンパク質産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Biogen Inc
    • Pfizer Inc
    • UCB SA
    • Leadiant Biosciences, Inc.
    • Amgen Inc.
    • Thermo Fisher Scientific Inc.
    • Horizon Therapeutics Plc.
    • Novo Nordisk A/S
    • F. Hoffmann-La Roche AG
    • Bayer AG
    • BioMarin
    • RedHill Biopharma Ltd.
    • Profacgen
    • Creative PEGworks
    • NOF America Corp.
    • Aurigene Pharmaceutical Services Ltd.
    • Laysan Bio, Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data Applications
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE PEGylated Proteins Market: Protein Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Protein Type
  • TABLE Global PEGylated Proteins Market, by Protein Type 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global PEGylated Proteins Market, by Application 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: End-Use Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-Use
  • TABLE Global PEGylated Proteins Market, by End-Use 2018-2030 (USD Million)
  • TABLE PEGylated Proteins Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global PEGylated Proteins Market, by Region 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE North America PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Protein Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa PEGylated Proteins Market, by End-Use, 2018-2030 (USD Million)

List of Figures

  • FIGURE PEGylated Proteins Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Protein Type segment market share analysis, 2022 & 2030
  • FIGURE Protein Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-Use segment market share analysis, 2022 & 2030
  • FIGURE End-Use segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America PEGylated Proteins Market share and leading players, 2022
  • FIGURE Europe PEGylated Proteins Market share and leading players, 2022
  • FIGURE Asia Pacific PEGylated Proteins Market share and leading players, 2022
  • FIGURE Latin America PEGylated Proteins Market share and leading players, 2022
  • FIGURE Middle East and Africa PEGylated Proteins Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Germany PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific PEGylated Proteins Market share analysis by country, 2022
  • FIGURE India PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Brazil PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa PEGylated Proteins Market share analysis by country, 2022
  • FIGURE Saudi Arabia PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA PEGylated Proteins Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1966

REPORT HIGHLIGHT

PEGylated Proteins Market size was valued at USD 14,424.3 Million in 2022, expanding at a CAGR of 4.7 % from 2023 to 2030.

Therapeutic biologics or molecules that were chemically changed by the addition of polyethylene glycol (PEG) chains are referred to as PEGylated proteins. This change is intended to improve the biologic's pharmacokinetic features, such as enhanced stability, longer bloodstream circulation duration, and decreased immunogenicity. PEGylation increases medication bioavailability, allowing for less frequent dosage and perhaps decreasing adverse effects. This technology is frequently utilized in the pharmaceutical industry to enhance the therapeutic profile of different biologics, such as proteins and peptides, making them more successful in the treatment of a variety of medical disorders such as cancer, autoimmune diseases, and hemophilia.

PEGylated Proteins Market- Market Dynamics

The need to enhance the therapeutic efficacy and patient experience in biologic drug treatments propel market demand

PEGylation has various benefits, including increased medication circulation throughout the body, less immunogenicity, and greater stability. This enables less frequent dosage, which may improve patient compliance and reduce the burden of chronic illness care. Furthermore, PEGylation has the potential to reduce side effects and adverse responses, making biologics more bearable and safer for patients. As a consequence, pharmaceutical firms and academics are continuing to investigate PEGylation as a technique for optimizing current biologics and developing innovative therapies, with the goal of eventually improving healthcare outcomes.

PEGylated Proteins Market- Key Insights

As per the analysis shared by our research analyst, the global PEGylated Proteins market is estimated to grow annually at a CAGR of around 4.7% over the forecast period (2023-2030)

The PEGylated Proteins industry is projected to grow at a significant rate due to the need to enhance the therapeutic efficacy and patient experience in biologic drug treatments.

Based on Protein Type segmentation, Colony-stimulating Factors was predicted to show maximum market share in the year 2022

Based on Application segmentation, Autoimmune Diseases was the leading Protein Type in 2022

On the basis of region, North America was the leading revenue generator in 2022

PEGylated Proteins Market- Segmentation Analysis:

The Global PEGylated Proteins Market is segmented on the basis of Protein Type, Application, End-Use, and Region.

The market is divided into four categories based on Protein Type: Colony-stimulating Factors, Interferons, Erythropoietin, and Others. The Colony-stimulating Factors dominates the market. PEGylated proteins, especially PEGylated colony-stimulating factors, are in high demand due to their usage in a variety of medicinal applications. Colony-stimulating factors, which increase the creation of blood cells, are often PEGylated to improve their therapeutic effectiveness in illnesses such as cancer, anaemia, and immunodeficiency disorders.

The market is divided into three categories based on Application: Cancer, Autoimmune Diseases, Hepatitis, Multiple Sclerosis, Hemophilia, Gastrointestinal Disorders, and Others. The Autoimmune Diseases sector dominates the market and is likely to maintain its dominance during the forecast period. PEGylated proteins are in high demand for use in autoimmune disorders. These biologics may provide prolonged half-lives and enhanced efficacy in treating illnesses such as rheumatoid arthritis, multiple sclerosis, and lupus by modulating immune responses and lowering inflammation by altering autoimmune-related proteins using polyethylene glycol (PEG).

PEGylated Proteins Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables influence the market for PEGylated proteins in North America. The area boasts a well-established pharmaceutical and biotechnology sector devoted to the development and commercialization of innovative biologic medicines. Additionally, the increasing frequency of chronic illnesses such as cancer, autoimmune disorders, and blood disorders has boosted the need for tailored biologic therapies. Furthermore, the regulatory framework in North America fosters innovation and the development of innovative medicine formulations, such as PEGylated proteins, which enhance treatment results and patient compliance. Finally, the region's strong healthcare infrastructure and availability of cutting-edge therapies make it a good market for PEGylated protein therapeutics, fueling continuous research and investment in this sector.

PEGylated Proteins Market- Competitive Landscape:

The competitive environment for PEGylated proteins is dynamic and varied. Leading pharmaceutical and biotechnology firms such as Roche, Amgen, and Novo Nordisk have made significant investments in the development of PEGylated biologics such as monoclonal antibodies and cytokines. However, there are also creative startups and specialized biotech corporations in the sector, such as Nektar Therapeutics, which focuses only on PEGylation technology. This variety encourages innovation and competitiveness, pushing for breakthroughs in drug delivery and increasing biologics' therapeutic profile. The competitive environment continues to change as the need for focused and long-lasting biologic medicines develops, with an emphasis on producing more effective and patient-friendly PEGylated protein therapeutics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PEGYLATED PROTEINS MARKET KEY PLAYERS

  • Biogen Inc
  • Pfizer Inc
  • UCB S.A.
  • Leadiant Biosciences, Inc.
  • Amgen Inc.
  • Thermo Fisher Scientific Inc.
  • Horizon Therapeutics Plc.
  • Novo Nordisk A/S
  • F. Hoffmann-La Roche AG
  • Bayer AG
  • BioMarin
  • RedHill Biopharma Ltd.
  • Profacgen
  • Creative PEGworks
  • NOF America Corp.
  • Aurigene Pharmaceutical Services Ltd.
  • Laysan Bio, Inc.

GLOBAL PEGYLATED PROTEINS MARKET, BY PROTEIN TYPE

  • Colony-stimulating Factors
  • Interferons
  • Erythropoietin
  • Others

GLOBAL PEGYLATED PROTEINS MARKET, BY APPLICATION

  • Cancer
  • Autoimmune Diseases
  • Hepatitis
  • Multiple Sclerosis
  • Hemophilia
  • Gastrointestinal Disorders
  • Others

GLOBAL PEGYLATED PROTEINS MARKET, BY END-USE

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations
  • Academic & Research Institutes

GLOBAL PEGYLATED PROTEINS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. PEGylated Proteins Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. PEGylated Proteins Market Snippet by Protein Type
    • 2.1.2. PEGylated Proteins Market Snippet by Application
    • 2.1.3. PEGylated Proteins Market Snippet by End-Use
    • 2.1.4. PEGylated Proteins Market Snippet by Country
    • 2.1.5. PEGylated Proteins Market Snippet by Region
  • 2.2. Competitive Insights

3. PEGylated Proteins Key Market Trends

  • 3.1. PEGylated Proteins Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. PEGylated Proteins Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. PEGylated Proteins Market Opportunities
  • 3.4. PEGylated Proteins Market Future Trends

4. PEGylated Proteins Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. PEGylated Proteins Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. PEGylated Proteins Market Landscape

  • 6.1. PEGylated Proteins Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. PEGylated Proteins Market - By Protein Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Protein Type, 2022 & 2030 (%)
    • 7.1.2. Colony-stimulating Factors
    • 7.1.3. Interferons
    • 7.1.4. Erythropoietin
    • 7.1.5. Others

8. PEGylated Proteins Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Cancer
    • 8.1.3. Autoimmune Diseases
    • 8.1.4. Hepatitis
    • 8.1.5. Multiple Sclerosis
    • 8.1.6. Hemophilia
    • 8.1.7. Gastrointestinal Disorders
    • 8.1.8. Others

9. PEGylated Proteins Market - By End-Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End-Use, 2022 & 2030 (%)
    • 9.1.2. Pharmaceutical & Biotechnology Companies
    • 9.1.3. Contract Research Organizations
    • 9.1.4. Academic & Research Institutes

10. PEGylated Proteins Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. PEGylated Proteins Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. PEGylated Proteins Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. PEGylated Proteins Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. PEGylated Proteins Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. PEGylated Proteins Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Protein Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End-Use, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- PEGylated Proteins Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Biogen Inc
    • 11.2.2. Pfizer Inc
    • 11.2.3. UCB S.A.
    • 11.2.4. Leadiant Biosciences, Inc.
    • 11.2.5. Amgen Inc.
    • 11.2.6. Thermo Fisher Scientific Inc.
    • 11.2.7. Horizon Therapeutics Plc.
    • 11.2.8. Novo Nordisk A/S
    • 11.2.9. F. Hoffmann-La Roche AG
    • 11.2.10. Bayer AG
    • 11.2.11. BioMarin
    • 11.2.12. RedHill Biopharma Ltd.
    • 11.2.13. Profacgen
    • 11.2.14. Creative PEGworks
    • 11.2.15. NOF America Corp.
    • 11.2.16. Aurigene Pharmaceutical Services Ltd.
    • 11.2.17. Laysan Bio, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us